SCHEMBL24718822

SCHEMBL24718822

Cc1ccc(O)c(C(=O)N[C@@H]2CC(O)N(Cc3ccc(C(F)(F)F)cc3)C2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 2/20 0.45
▸ TMPRSS4 Q9NRS4 2/20 0.45
▸ CCR2 P41597 2/20 0.41
▸ DRD4 P21917 4/20 0.41
▸ DRD2 P14416 2/20 0.39
▸ HTR2A P28223 1/20 0.39
▸ PHGDH O43175 4/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ P2RX4 Q99571 1/20 0.38
▸ P2RX7 Q99572 1/20 0.38
▸ UBE2M P61081 1/20 0.38
▸ DCUN1D1 Q96GG9 1/20 0.38
▸ TEAD1 P28347 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ CRHR1 P34998 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24719132 0.85 MEN1 (0.43) DRD4DRD2HTR2AKDM4E
SCHEMBL24718656 0.85 MEN1 (0.43) DRD4DRD2HTR2AKDM4E
SCHEMBL24718430 0.81 P2RX1 (0.45) P2RX1TMPRSS4CCR2DRD4HSP90AA1
SCHEMBL24718823 0.81 P2RX1 (0.45) P2RX1TMPRSS4CCR2DRD4HSP90AA1
SCHEMBL24460414 0.68 P2RX1 (0.80) P2RX1TMPRSS4HTR2AP2RX4P2RX7
SCHEMBL24718415 0.66 TP53 (0.49) P2RX1TMPRSS4P2RX7KDM4EALDH1A1
SCHEMBL24718657 0.66 SMN1; SMN2 (0.44) KDM4EALDH1A1
SCHEMBL24719133 0.66 SMN1; SMN2 (0.44) KDM4EALDH1A1
SCHEMBL24719112 0.66 SMN1; SMN2 (0.44) KDM4EALDH1A1
Trifluoroacetic Acid SCHEMBL31571888 0.64 TAS1R3 (0.49) P2RX1TMPRSS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING UNITED STATES GOVERNMENT 2022-11-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220363633-A1 SUBSTITUTED PYRROLIDONES AND PIPERIDONES AS SMALL MOLECULE INHIBITORS OF EZH2 AND EED PROTEIN BINDING EED, EZH2, ELP1 P2RX1 4064/4885TMPRSS4 3201/4885CCR2 3257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback